{"id":"https://openalex.org/W4231147644","doi":"https://doi.org/10.1159/000104193","title":"Abacavir Hypersensitivity","display_name":"Abacavir Hypersensitivity","publication_year":2007,"publication_date":"2007-01-01","ids":{"openalex":"https://openalex.org/W4231147644","doi":"https://doi.org/10.1159/000104193"},"language":"en","primary_location":{"id":"doi:10.1159/000104193","doi":"https://doi.org/10.1159/000104193","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000104193","pdf_url":null,"source":{"id":"https://openalex.org/S4306463508","display_name":"KARGER eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Hypersensitivity","raw_type":"book-chapter"},"volume":{"id":"https://openalex.org/W4236808222","display_name":"Drug Hypersensitivity"},"type":"book-chapter","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039351765","display_name":"David A Nolan","orcid":"https://orcid.org/0000-0002-0743-8801","observed_orcids":["https://orcid.org/0000-0002-0743-8801"]},"institutions":[{"id":"https://openalex.org/I176790772","display_name":"Murdoch University","ror":"https://ror.org/00r4sry34","country_code":"AU","type":"education","lineage":["https://openalex.org/I176790772"]},{"id":"https://openalex.org/I2799740997","display_name":"Royal Perth Hospital","ror":"https://ror.org/00zc2xc51","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2799506148","https://openalex.org/I2799740997","https://openalex.org/I2800882159","https://openalex.org/I4388446364","https://openalex.org/I4405257575"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"David Nolan","raw_affiliation_strings":["Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University,\nPerth , Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University,\nPerth , Australia","institution_ids":["https://openalex.org/I176790772","https://openalex.org/I2799740997"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109383862","display_name":"Coral-Ann M. Almeida","orcid":"https://orcid.org/0009-0001-8686-893X","observed_orcids":["https://orcid.org/0009-0001-8686-893X"]},"institutions":[{"id":"https://openalex.org/I176790772","display_name":"Murdoch University","ror":"https://ror.org/00r4sry34","country_code":"AU","type":"education","lineage":["https://openalex.org/I176790772"]},{"id":"https://openalex.org/I2799740997","display_name":"Royal Perth Hospital","ror":"https://ror.org/00zc2xc51","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2799506148","https://openalex.org/I2799740997","https://openalex.org/I2800882159","https://openalex.org/I4388446364","https://openalex.org/I4405257575"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Coral-Ann Almeida","raw_affiliation_strings":["Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University,\nPerth , Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University,\nPerth , Australia","institution_ids":["https://openalex.org/I176790772","https://openalex.org/I2799740997"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080985934","display_name":"Elizabeth Jane Phillips","orcid":"https://orcid.org/0000-0002-7623-3383","observed_orcids":["https://orcid.org/0000-0002-7623-3383"]},"institutions":[{"id":"https://openalex.org/I176790772","display_name":"Murdoch University","ror":"https://ror.org/00r4sry34","country_code":"AU","type":"education","lineage":["https://openalex.org/I176790772"]},{"id":"https://openalex.org/I2799740997","display_name":"Royal Perth Hospital","ror":"https://ror.org/00zc2xc51","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2799506148","https://openalex.org/I2799740997","https://openalex.org/I2800882159","https://openalex.org/I4388446364","https://openalex.org/I4405257575"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Elizabeth Phillips","raw_affiliation_strings":["Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University,\nPerth , Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University,\nPerth , Australia","institution_ids":["https://openalex.org/I176790772","https://openalex.org/I2799740997"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070165631","display_name":"Simon Alexander Mallal","orcid":"https://orcid.org/0000-0002-7036-1309","observed_orcids":["https://orcid.org/0000-0002-7036-1309"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Simon Mallal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.40943114,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":null,"issue":null,"first_page":"95","last_page":"104"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/abacavir-hypersensitivity","display_name":"abacavir hypersensitivity","score":0.949999988079071},{"id":"https://openalex.org/keywords/hla-b-57-01","display_name":"HLA-B*57:01","score":0.949999988079071},{"id":"https://openalex.org/keywords/nucleoside-reverse-transcriptase-inhibitors","display_name":"nucleoside reverse transcriptase inhibitors","score":0.9120000004768372},{"id":"https://openalex.org/keywords/hiv-treatment","display_name":"HIV treatment","score":0.7210000157356262},{"id":"https://openalex.org/keywords/genetic-susceptibility","display_name":"genetic susceptibility","score":0.6639999747276306},{"id":"https://openalex.org/keywords/cd8-t-cell-responses","display_name":"CD8+ T cell responses","score":0.7049999833106995},{"id":"https://openalex.org/keywords/drug-induced-rash","display_name":"drug rash","score":0.4699999988079071},{"id":"https://openalex.org/keywords/pharmacogenetics","display_name":"pharmacogenetics","score":0.546999990940094}],"concepts":[{"id":"https://openalex.org/C2779465607","wikidata":"https://www.wikidata.org/wiki/Q304330","display_name":"Abacavir","level":5,"score":0.9950610995292664},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.6112834215164185},{"id":"https://openalex.org/C188280979","wikidata":"https://www.wikidata.org/wiki/Q911125","display_name":"Human leukocyte antigen","level":3,"score":0.6094140410423279},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5405965447425842},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.5005741119384766},{"id":"https://openalex.org/C67636389","wikidata":"https://www.wikidata.org/wiki/Q784237","display_name":"Genetic predisposition","level":3,"score":0.47816166281700134},{"id":"https://openalex.org/C180754005","wikidata":"https://www.wikidata.org/wiki/Q80726","display_name":"Allele","level":3,"score":0.4445897340774536},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.26243239641189575},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2415737509727478},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.22060701251029968},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.16922453045845032},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1649354100227356},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.15066462755203247},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.13764029741287231},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.10191372036933899},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.09921884536743164},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0694902241230011}],"mesh":[],"locations_count":7,"locations":[{"id":"doi:10.1159/000104193","doi":"https://doi.org/10.1159/000104193","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000104193","pdf_url":null,"source":{"id":"https://openalex.org/S4306463508","display_name":"KARGER eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Hypersensitivity","raw_type":"book-chapter"},{"id":"pmh:oai:alma.61MUN_INST:11135387260007891","doi":null,"is_oa":false,"landing_page_url":"https://researchportal.murdoch.edu.au/esploro/outputs/bookChapter/Abacavir-hypersensitivity/991005541129807891","pdf_url":null,"source":{"id":"https://openalex.org/S4306400274","display_name":"Murdoch University Research Portal","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I176790772","host_organization_name":"Murdoch University","host_organization_lineage":["https://openalex.org/I176790772"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Book Section"},{"id":"pmh:oai:alma.61MUN_INST:11136519310007891","doi":null,"is_oa":false,"landing_page_url":"https://researchportal.murdoch.edu.au/esploro/outputs/bookChapter/Abacavir-hypersensitivity/991005545067407891","pdf_url":null,"source":{"id":"https://openalex.org/S4306400274","display_name":"Murdoch University Research Portal","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I176790772","host_organization_name":"Murdoch University","host_organization_lineage":["https://openalex.org/I176790772"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Book Section"},{"id":"pmh:oai:alma.61MUN_INST:11136553610007891","doi":null,"is_oa":false,"landing_page_url":"https://researchportal.murdoch.edu.au/esploro/outputs/bookChapter/Abacavir-hypersensitivity/991005545153707891","pdf_url":null,"source":{"id":"https://openalex.org/S4306400274","display_name":"Murdoch University Research Portal","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I176790772","host_organization_name":"Murdoch University","host_organization_lineage":["https://openalex.org/I176790772"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Book Section"},{"id":"pmh:oai:researchrepository.murdoch.edu.au:16130","doi":null,"is_oa":false,"landing_page_url":"http://researchrepository.murdoch.edu.au/id/eprint/16130/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400274","display_name":"Murdoch University Research Portal","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I176790772","host_organization_name":"Murdoch University","host_organization_lineage":["https://openalex.org/I176790772"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Nolan, D. <http://researchrepository.murdoch.edu.au/view/author/Nolan, David.html>, Almeida, C. <http://researchrepository.murdoch.edu.au/view/author/Almeida, Coral-Ann.html> and Phillips, E.J. <http://researchrepository.murdoch.edu.au/view/author/Phillips, Elizabeth.html> (2007) Abacavir hypersensitivity. In: Pichler, W., (ed.) Drug Hypersensitivity. S. Karger AG, Basel, Switzerland, pp. 116-125.","raw_type":"Book Chapter"},{"id":"pmh:oai:researchrepository.murdoch.edu.au:17658","doi":null,"is_oa":false,"landing_page_url":"http://researchrepository.murdoch.edu.au/id/eprint/17658/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400274","display_name":"Murdoch University Research Portal","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I176790772","host_organization_name":"Murdoch University","host_organization_lineage":["https://openalex.org/I176790772"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Book Chapter"},{"id":"pmh:oai:researchrepository.murdoch.edu.au:37358","doi":null,"is_oa":false,"landing_page_url":"http://researchrepository.murdoch.edu.au/id/eprint/37358/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400274","display_name":"Murdoch University Research Portal","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I176790772","host_organization_name":"Murdoch University","host_organization_lineage":["https://openalex.org/I176790772"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Nolan, D. <http://researchrepository.murdoch.edu.au/view/author/Nolan, David.html>, Almeida, C. <http://researchrepository.murdoch.edu.au/view/author/Almeida, Coral-Ann.html> and Phillips, E. <http://researchrepository.murdoch.edu.au/view/author/Phillips, Elizabeth.html> (2007) Abacavir hypersensitivity. In: Pichler, Werner J., (ed.) Drug Hypersensitivity. S.Karger AG, Basel, Switzerland.","raw_type":"Book Chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2043901478","https://openalex.org/W2140055542","https://openalex.org/W1976854377","https://openalex.org/W1567512524","https://openalex.org/W2126390350","https://openalex.org/W2073270356","https://openalex.org/W2122329447","https://openalex.org/W2102942667","https://openalex.org/W1970844378","https://openalex.org/W2337681186"],"abstract_inverted_index":{"Abacavir":[0],"is":[1,25,62,105],"a":[2,69,109,132],"commonly":[3],"prescribed":[4],"HIV":[5],"drug":[6,30,59],"belonging":[7],"to":[8,57,107],"the":[9,66,83,118,140,151],"nucleoside":[10],"reverse":[11],"transcriptase":[12],"inhibitor":[13],"(NRTI)":[14],"class.":[15],"The":[16,95],"major":[17],"treatment-limiting":[18],"side":[19],"effect":[20],"associated":[21],"with":[22],"its":[23,166],"use":[24],"an":[26],"early":[27],"onset":[28],"multi-system":[29],"hypersensitivity":[31,60,89],"reaction":[32],"typically":[33],"including":[34],"some":[35],"combination":[36],"of":[37,47,53,68,98,121,142,153,165],"rash,":[38],"fever":[39],"and":[40,92],"gastrointestinal":[41],"symptoms,":[42],"occurring":[43],"within":[44],"6":[45],"weeks":[46],"initiating":[48],"treatment":[49],"in":[50,102,115,124,139],"approximately":[51],"5-8%":[52],"abacavir":[54,88],"recipients.":[55],"Susceptibility":[56],"this":[58,99,136,147,154],"syndrome":[61],"strongly":[63],"predicted":[64],"by":[65],"presence":[67],"specific":[70],"human":[71],"leukocyte":[72],"antigen":[73],"(HLA)":[74],"allele":[75],"-":[76,80],"HLA-B":[77],"*":[78],"5701":[79,123],"which":[81],"represents":[82],"dominant":[84],"risk":[85],"factor":[86],"for":[87,112,135,157],"among":[90],"Caucasian":[91],"Hispanic":[93],"populations.":[94],"frequency":[96],"distribution":[97],"genetic":[100,137,155],"marker":[101],"different":[103],"populations":[104],"likely":[106],"provide":[108],"rational":[110],"basis":[111],"racially-defined":[113],"differences":[114],"susceptibility,":[116],"while":[117],"critical":[119],"role":[120,134],"HLAB*":[122],"directing":[125],"CD8+":[126],"T-cell-dependent,":[127],"HLA-restricted":[128],"immune":[129,144],"responses":[130],"provides":[131],"key":[133],"variant":[138],"pathogenesis":[141],"abacavir-specific":[143],"responses.":[145],"In":[146],"chapter,":[148],"we":[149],"review":[150],"implications":[152],"association":[156],"clinical":[158],"practice":[159],"as":[160,162],"well":[161],"current":[163],"knowledge":[164],"immunological":[167],"basis.":[168]},"counts_by_year":[{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2022-05-11T00:00:00"}